Buzz Stocks: NVIDIA Corporation, Merck & Co., Inc., and Medivation Inc

Today's stocks to watch in the news include NVIDIA Corporation (NASDAQ:NVDA), Merck & Co., Inc. (NYSE:MRK), and Medivation Inc (NASDAQ:MDVN)

by Karee Venema

Published on Jul 31, 2015 at 9:28 AM
Updated on Jul 31, 2015 at 9:34 AM

Futures are in the red this morning, as traders digest a fresh round of economic data -- as well as a merciless month for China's Shanghai Composite. Among specific equities in focus are semiconductor concern NVIDIA Corporation (NASDAQ:NVDA), as well as drugmakers Merck & Co., Inc. (NYSE:MRK) and Medivation Inc (NASDAQ:MDVN).

  • NVDA -- which will take its turn in the earnings confessional after next Thursday's close -- announced today it is recalling about 83,000 of its 8-inch Shield tablets due to a potential battery fire hazard. The news is having little impact on NVDA in electronic trading, with the stock lingering near last night's close at $20.02. Longer term, the security has been consolidating in the $19-to-$20 region since hitting a four-year high of $23.60 in late March. Option traders, meanwhile, having been upping the bearish ante in recent months -- which could be to their detriment, if history is any guide. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), NVIDIA Corporation's 50-day put/call volume ratio of 1.20 ranks just 1 percentage point from a 52-week peak.

  • It's been a big week for MRK on the fundamental front, and today, Wall Street is digesting reports that the blue-chip's fast-tracked experimental Ebola vaccine has been 100% effective in its Guinea trial. At last check, the shares were up 1.4% ahead of the bell -- after settling Thursday at $58.52 -- and edging toward their Jan. 13 12-year peak of $63.62. In the options pits, short-term speculators are more put-skewed than usual, per Merck & Co., Inc.'s Schaeffer's put/call open interest ratio (SOIR) of 0.82, which sits higher than 72% of all similar readings taken in the past year. Echoing this is MRK's 10-day ISE/CBOE/PHLX put/call volume ratio of 0.78, which rests in the 74th annual percentile.

  • News of a 2-for-1 stock split has shares of MDVN up 12% in electronic trading -- and poised to pop back above the century level, their 320-day moving average, and their year-to-date breakeven mark. In fact, each of these areas were comprised earlier this week, when reports suggesting slowing demand for the company's cancer drug, Xtandi, were met with bearish backlash from the brokerage bunch. Overall, analysts are bullish on Medivation Inc, with 10 "strong buys" versus three "hold" or worse ratings. Plus, the average 12-month price target of $137.40 stands at a 42% premium to Thursday's close at $96.97.

Want an even earlier advantage on the biggest news before the bell? Sign up now to get Schaeffer's Opening View delivered straight to your inbox!


A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.
Google Postpones Android Reveal, "Now is Not the Time to Celebrate"
"Now is not the time to celebrate," Google said in a message on its website
ZNGA Zooms to 8-Year High on Billion-Dollar Deal
ZNGA is planning to buy Peak for $1.8 billion
Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....